SG104087G - Crystalline benzenesulfonate salts of sultamicillin - Google Patents

Crystalline benzenesulfonate salts of sultamicillin

Info

Publication number
SG104087G
SG104087G SG1040/87A SG104087A SG104087G SG 104087 G SG104087 G SG 104087G SG 1040/87 A SG1040/87 A SG 1040/87A SG 104087 A SG104087 A SG 104087A SG 104087 G SG104087 G SG 104087G
Authority
SG
Singapore
Prior art keywords
sultamicillin
benzenesulfonate salts
crystalline benzenesulfonate
crystalline
salts
Prior art date
Application number
SG1040/87A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG104087G publication Critical patent/SG104087G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG1040/87A 1982-04-23 1987-11-25 Crystalline benzenesulfonate salts of sultamicillin SG104087G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (1)

Publication Number Publication Date
SG104087G true SG104087G (en) 1988-07-15

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1040/87A SG104087G (en) 1982-04-23 1987-11-25 Crystalline benzenesulfonate salts of sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (h)
EP (1) EP0092968B1 (h)
JP (1) JPS58201792A (h)
KR (1) KR860001279B1 (h)
AU (1) AU536854B2 (h)
CA (1) CA1187484A (h)
CS (1) CS235320B2 (h)
DD (1) DD209632A5 (h)
DE (1) DE3362502D1 (h)
DK (1) DK162168C (h)
EG (1) EG16412A (h)
ES (1) ES8406075A1 (h)
FI (1) FI76092C (h)
GR (1) GR78582B (h)
HK (1) HK20588A (h)
HU (1) HU187068B (h)
IE (1) IE54628B1 (h)
IL (1) IL68453A (h)
NO (1) NO156202C (h)
NZ (1) NZ203988A (h)
PH (1) PH18035A (h)
PL (1) PL134978B1 (h)
PT (1) PT76587B (h)
SG (1) SG104087G (h)
SU (1) SU1138030A3 (h)
YU (1) YU43170B (h)
ZA (1) ZA832845B (h)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
JPH07110815B2 (ja) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上(およびスペクトルシフト)のためのポリキレ−ト剤
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co., Ltd. Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
BR0313831A (pt) 2002-08-29 2005-07-05 Taisho Pharmaceutical Co Ltd Sais benzenossulfonato de derivados de 4-flúor-2-cianopirrolidina
PT1606293E (pt) * 2003-03-27 2009-10-14 Basilea Pharmaceutica Ag Cefalosporina sob forma cristalina
WO2005041924A2 (en) * 2003-10-31 2005-05-12 Alza Corporation Administration of levodopa and carbidopa
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
AU2008290329B2 (en) 2007-08-22 2011-12-22 Astrazeneca Ab Cyclopropyl amide derivatives
WO2009055053A2 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds as androgen receptor modulators
MY161598A (en) * 2009-01-30 2017-04-28 Glaxosmithkline Llc Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
WO2011006061A1 (en) * 2009-07-10 2011-01-13 Evolva Sa Diyne compositions
AU2011218490B9 (en) * 2010-02-18 2014-12-18 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
CA2788444A1 (en) * 2010-02-18 2011-08-25 Astrazeneca Ab New crystalline form of a cyclopropyl benzamide derivative
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素q10誘導体およびその製造方法
CN105517992B (zh) * 2013-09-05 2018-06-22 田边三菱制药株式会社 新型结晶性芳烷基胺化合物及其制造方法
CA2965169C (en) 2014-10-21 2021-11-16 Ariad Pharmaceuticals, Inc. Crystalline forms of 5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidine-2,4-diamine
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
WO2017125557A1 (en) * 2016-01-22 2017-07-27 Sandoz Ag Crystalline eravacycline bis-hydrochloride
MA45588A (fr) * 2016-07-07 2019-05-15 Ironwood Pharmaceuticals Inc Formes solides d'un stimulateur de la gcs
WO2019089540A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic arenesulfonate salts
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
WO2022174134A1 (en) * 2021-02-15 2022-08-18 Propella Therapeutics, Inc. Abiraterone prodrugs
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
US11851424B2 (en) * 2021-05-14 2023-12-26 Global Blood Therapeutics, Inc. Solid forms of a modulator of hemoglobin
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
WO2023125700A1 (zh) * 2021-12-28 2023-07-06 南京明德新药研发有限公司 四氢环庚吲唑化合物的盐型、晶型
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
TW202517651A (zh) * 2023-07-17 2025-05-01 美商庫拉腫瘤技術股份有限公司 Menin抑制劑之晶型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
KR830001903B1 (ko) * 1979-02-13 1983-09-19 레오 파마슈티칼 프로덕츠 리미티드 페니실란산유도체의 제조방법
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK101783D0 (da) 1983-02-28
PT76587B (en) 1986-02-27
GR78582B (h) 1984-09-27
FI76092C (fi) 1988-09-09
HU187068B (en) 1985-11-28
DD209632A5 (de) 1984-05-16
DK101783A (da) 1983-10-24
SU1138030A3 (ru) 1985-01-30
JPH0119395B2 (h) 1989-04-11
IE54628B1 (en) 1989-12-20
EP0092968A1 (en) 1983-11-02
JPS58201792A (ja) 1983-11-24
ES521728A0 (es) 1984-07-01
PL241553A1 (en) 1983-11-21
PT76587A (en) 1983-05-01
PH18035A (en) 1985-03-06
AU1387183A (en) 1983-11-17
EG16412A (en) 1989-03-30
NO156202C (no) 1987-08-19
DE3362502D1 (en) 1986-04-17
NO156202B (no) 1987-05-04
EP0092968B1 (en) 1986-03-12
IE830926L (en) 1983-10-23
KR860001279B1 (ko) 1986-09-05
KR840004437A (ko) 1984-10-15
ZA832845B (en) 1984-11-28
FI76092B (fi) 1988-05-31
FI831392A0 (fi) 1983-04-22
FI831392L (fi) 1983-10-24
CA1187484A (en) 1985-05-21
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
IL68453A0 (en) 1983-07-31
DK162168C (da) 1992-03-02
AU536854B2 (en) 1984-05-24
DK162168B (da) 1991-09-23
US4432987A (en) 1984-02-21
CS235320B2 (en) 1985-05-15
IL68453A (en) 1986-08-31
PL134978B1 (en) 1985-09-30
YU90483A (en) 1986-04-30
HK20588A (en) 1988-03-25
YU43170B (en) 1989-04-30
ES8406075A1 (es) 1984-07-01

Similar Documents

Publication Publication Date Title
DE3362502D1 (en) Crystalline benzenesulfonate salts of sultamicillin
GB8515980D0 (en) Mixture of salts
GB2128926B (en) Crystallisation of thermoplastic
YU42767B (en) Process for obtaining crystalline salts of benzothiazin-dioxide
DE3374305D1 (en) Process for the preparation of quaternary ammonium salts
ZA839593B (en) Crystalline cephem-acid addition salts and processes for their preparation
GB8316168D0 (en) Crystalline gallosilicates
PT81274A (en) Process for the preparation of substituted 2-furanylalkoxyalkylcyclimmonium or 5-oxo-2-furanylalkoxyalkycyclimmonium salts
ZA852042B (en) Crystalline ceftazidime salts
PT80999B (en) Process for the preparation of cyclimmonium salts
KE3785A (en) Crystalline benzenesulfonate salts of sultamicillin
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
GB2158828B (en) Salts of fosfomycin
AU553252B2 (en) Crystalline salts of cefodizim
IL69566A0 (en) Crystallizable salts of a thiovinyl cephalosporin derivative and methods for the preparation of same
GB8406435D0 (en) Single crystalline dl-cysteine
EP0201055A3 (en) Process for the preparation of halogenide-free quaternary ammonium salts
GB8302317D0 (en) Crystalline form of sodium
GB8414046D0 (en) Crystalline salts
SU1075479A1 (ru) Выпарной аппарат для кристаллизации растворов
PH20301A (en) Bis-alkylphosphonium salts of n-phosphonomethylglycine
GB8709633D0 (en) Crystalline compounds
PL237537A1 (en) Method of manufacture of crystalline microcellulose
GB8329750D0 (en) 5-phenoxybenzoic acid derivatives of pentites